Main Subject
#1 in Business Subscribe Email Print

You are here: Home > Business > Change Management > Do Not Depend Solely on the Doctor in the House to do the Surgery

Tags

  • employees
  • suited
  • process
  • developing combination

  • Links

  • End Your Nicotine Addiction Today
  • News of Antioxidants in Coffee not a License to Make It a Mainstay in Health Regimens
  • Foreclosures Are Increasing, Will You Bite?
  • Main Subject - Do Not Depend Solely on the Doctor in the House to do the Surgery

    Many business leaders are good at starting a business or maintaining one that has already been well established. However, they are not good at fixing a seriously
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    sick business. Avoid bankruptcy by hiring the turnaround experts.

    They often do not have the experience, skills, temperament or willingness to do a proper turn
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    around. Sometimes, the business leader himself is the hindrance and obstacle to the entire turnaround process because of past encumbrances and prejudices. An out
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    sider is quite often required to execute the turnaround.

    Most of the time, a troubled company cannot be fixed solely from the within. The management may harbo
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ur too much prejudices, vested interests and baggage. If the medicine is too bitter, management may not have the guts to swallow it. The company needs somebody
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    from the outside who is able to say “no” firmly when necessary. If the internal management is the cause of the internal woes, then the use of internal manageme
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    nt for the turnaround is like using leeches to cure leukaemia. The condition of the patient will not improve and may deteriorate as time passes by.

    An outsider
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    brings some unfair advantages to the turnaround game. You have no emotional baggage tied to a new dream or a historically interesting but economically irreleva
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    nt service. Nor are you beholden to the big bosses. You can ask dump questions without looking dumb. One or two of those dumb questions will turn out to be brill
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    iant ones.

    Contrary to expectations, you will find you are accorded loyalty from employees. Other executives have to work hard to earn this devotion. These em
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    loyees understand that you represent their last chance, and that you did not create the problem. They knew that the business was wobbling off course before the
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    board or owners understood it. With the right demeanour and without rudeness, the employees will guide you immediately toward the major problems. Few will hol
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    d back if you listen hard. They know that if you really quiz them and they will lose their jobs anyway, it is less painful for them, since both of you have tri
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ed to salvage the situation.

    Turnaround specialists coming from your specific industry are usually quite good. Their names are familiar in the industry and you
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    can check on the reputation of these specialists. They also probably already know something about your company.

    These specialists can make objective decisions t
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    at the ailing company’s management cannot. Some take on full-time positions within the company as the Chief Executive. Others may be engaged as consultants wit
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    h full authority and access to the company’s accounts. They are there to cover the wound, conduct surgery or resuscitation. Once the job is done, they move on
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    as these guys may not be the types suited to running a healthy company. Majority of executives are not suited for a turnaround as this unique situation demands
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    extraordinary leadership. When these turnaround specialists take over the helm of the management, they swiftly proceed do the things that the Chief Executive o
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ught to be doing before the company gets into trouble – restructuring.

    When you are afflicted by cancer, see an oncologist and do not rely on your family doctor


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.mainsubjects.org.ua/article/13985/mainsubjects-Do-Not-Depend-Solely-on-the-Doctor-in-the-House-to-do-the-Surgery.html">Do Not Depend Solely on the Doctor in the House to do the Surgery</a>

    BB link (for phorums):
    [url=http://www.mainsubjects.org.ua/article/13985/mainsubjects-Do-Not-Depend-Solely-on-the-Doctor-in-the-House-to-do-the-Surgery.html]Do Not Depend Solely on the Doctor in the House to do the Surgery[/url]

    Related Articles:

    How to Define a Business

    Sticker Printing Made Easy

    Registered Nurse Jobs

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com